2021Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
The Journal of infectious diseases.224(11):1916-1924[DOI] 10.1093/infdis/jiab229.[PMID] 34009371.